Armed with Pfizer’s ADC Platform, Pyxis Scores $152M Round to Shoot for the Clinic while Taking its Time on I/O Programs April 2, 2021
Pfizer ships out 2 cancer ADCs alongside its tech platform to Pyxis Oncology, and its familiar CEO March 25, 2021
Pulmocide announces publication of clinical data in two peer-reviewed publications highlighting potential of PC945, a novel inhaled antifungal drug candidate, in lung infections March 11, 2021
